UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

Nature communications, 2020-10, Vol.11 (1), p.5415-5415, Article 5415

2020

Volltextzugriff (PDF)

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Nature communications, 2021-03, Vol.12 (1), p.1402-1402, Article 1402

2021

Volltextzugriff (PDF)

Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer

Scientific reports, 2021-11, Vol.11 (1), p.21992-21992, Article 21992

2021

Volltextzugriff (PDF)

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time

Journal of cancer research and clinical oncology, 2021-11, Vol.147 (11), p.3211-3224

2021

Volltextzugriff (PDF)

HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells

Breast cancer research and treatment, 2021-02, Vol.186 (1), p.37-51

2021

Volltextzugriff (PDF)

Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma

Scientific reports, 2024-01, Vol.14 (1), p.2394-2394, Article 2394

2024

Volltextzugriff (PDF)

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells

Cancer Immunology, Immunotherapy, 2022-01, Vol.71 (1), p.137-151

2022

Volltextzugriff (PDF)

Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis

Endocrine Journal, 2020, Vol.67(12), pp.1215-1226

2020

Volltextzugriff (PDF)

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer

PloS one, 2021-06, Vol.16 (6), p.e0252822

2021

Volltextzugriff (PDF)

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer

BMC cancer, 2020-02, Vol.20 (1), p.160-160, Article 160

2020

Volltextzugriff (PDF)

ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines

Oncotarget, 2016-10, Vol.7 (43), p.70011-70027

2016

Volltextzugriff (PDF)

Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer

BMC cancer, 2022-03, Vol.22 (1), p.327-327, Article 327

2022

Volltextzugriff (PDF)

Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition

Oncotarget, 2018-05, Vol.9 (33), p.22986-23002

2018

Volltextzugriff (PDF)

Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer

Endocrine Journal, 2021, Vol.68(11), pp.1329-1336

2021

Volltextzugriff (PDF)

Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003827

2022

Volltextzugriff (PDF)

Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

BMC cancer, 2021-10, Vol.21 (1), p.1-1077, Article 1077

2021

Volltextzugriff (PDF)

The Advantage of Using an Optical See-Through Head-Mounted Display in Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study

Journal of clinical medicine, 2023-01, Vol.12 (2), p.512

2023

Volltextzugriff (PDF)

Surgical resection of the primary tumor prevents an undesirable locoregional condition and improves the quality of life in patients with anaplastic thyroid cancer

Surgery today (Tokyo, Japan), 2022-11, Vol.52 (11), p.1620-1626

2022

Volltextzugriff (PDF)

In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002432

2021

Volltextzugriff (PDF)

44 Corticosteroids decrease efficacy of immune checkpoint inhibitor therapy and correlate with compromised CD8+ T-cell differentiation in patients with non-small cell lung cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A51-A51

2023

Volltextzugriff (PDF)

Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer

ENDOCRINE JOURNAL, 2021, Vol.68 (11), p.1329-1336

2021

Volltextzugriff (PDF)

Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature

Thyroid research, 2021-06, Vol.14 (1), p.1-15, Article 15

2021

Volltextzugriff (PDF)

Fibroadenoma in a young male breast: A case report and review of the literature

Clinical case reports, 2021-11, Vol.9 (11), p.e05114-n/a

2021

Volltextzugriff (PDF)

464 Clonal replacement of tumor-infiltrating CD8+ T cells by induction and activation of tumor-residing Batf3-dependent dendritic cells

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A282-A283

2020

Volltextzugriff (PDF)

Abstract 1051: Preclinical analyses of synergistic effect of eribulin and paclitaxel for triple-negative breast cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1051-1051

2017

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(148)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(51)
Humans
(36)
Oncology
(23)
Female
(22)
Breast Cancer
(19)
Animals
(15)
Lymphocytes
(15)
Mice
(15)
Surgery
(15)
Technology
(14)
Tumors
(14)
Male
(12)
Aged
(11)
Chemotherapy
(11)
Middle Aged
(11)
Multidisciplinary Sciences
(11)
Patients
(11)
Prognosis
(11)
Science & Technology - Other Topics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time

HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells

Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells

Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer

ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines

Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer

Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transition

Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer

Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling

Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

The Advantage of Using an Optical See-Through Head-Mounted Display in Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study

Surgical resection of the primary tumor prevents an undesirable locoregional condition and improves the quality of life in patients with anaplastic thyroid cancer

In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models

44 Corticosteroids decrease efficacy of immune checkpoint inhibitor therapy and correlate with compromised CD8+ T-cell differentiation in patients with non-small cell lung cancer

Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer

Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature

Fibroadenoma in a young male breast: A case report and review of the literature

464 Clonal replacement of tumor-infiltrating CD8+ T cells by induction and activation of tumor-residing Batf3-dependent dendritic cells

Abstract 1051: Preclinical analyses of synergistic effect of eribulin and paclitaxel for triple-negative breast cancer

Suchergebnisse filtern